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Abstract 
 
Our objective was to test the hypotheses that conjugated linoleic acid (CLA) and/or tetradecylthioacetic 
acid (TTA) would have beneficial effects on the nutritional quality of rainbow trout (Oncorhynchus 
mykiss) through decreased lipid content of flesh or viscera, and increased levels of beneficial fatty acids 
including accumulation of CLA or TTA themselves.  The specific aims of this study were to determine 
the effects of CLA and TTA on growth performance, lipid and fatty acid metabolism, and selected gene 
expression in commercial sized trout grown in seawater.  Trout were fed for eight weeks on fish meal 
and fish oil diets containing either 0.5% or 1% CLA, or 0.5% TTA.   The effects of the supplemented 
fatty acids on growth, feed efficiency, lipid contents, class compositions and fatty acid compositions of 
flesh and liver were determined, along with liver highly unsaturated fatty acid synthesis, activities of 
key enzymes of fatty acid oxidation in liver and muscle, and expression of carnitine 
palmitoyltransferase-I (CPT-I) and fatty acyl desaturase and elongase genes.  Neither functional fatty 
acid had any effect on growth parameters, condition factor, viscero- and hepato-somatic indices or fillet 
colour, and there were no mortalities in any of the treatments. Dietary CLA, but not TTA, decreased 
the lipid content of liver, but neither fatty acid had any significant effect on lipid class compositions of 
liver and flesh. Both CLA and TTA were incorporated into tissue lipids, with higher percentages found 
in flesh compared to liver.  In addition, production of hexaene fatty acid by liver microsomes was 
increased by dietary CLA or TTA, and both functional fatty acids increased the proportion of n-3 fatty 
acids in liver mainly due to increased 20:5n-3 and 22:6n-3. However, the expression of fatty acyl Δ6 
desaturase was significantly lower in fish fed CLA or TTA, whereas the expression of PUFA elongase 
was increased, significantly so in fish fed 1% CLA. CPT-I activity was increased by TTA in liver and 
red muscle, and acyl CoA oxidase activity was increased by TTA in liver and CLA at the higher dietary 
inclusion level in red muscle. There was a clear trend for CPT-I expression to be increased in fish fed 
0.5% CLA or TTA in all tissues although this was only significant in white muscle. The results showed 
that both CLA and TTA had effects on lipid metabolism that partly support the hypotheses tested.  
Although CLA or TTA did not enhance growth parameters, feed conversion or potential yield, 
nutritional quality could be enhanced, and sea-run trout fed CLA or TTA could be beneficial in the 
human diet through provision of bioactive fatty acids, with no detrimental effects on 20:5n-3 or 22:6n-
3 levels. 
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1. Introduction 
 
High lipid levels are utilized in commercial aquaculture diets in order to offset relatively expensive 
protein as a source of energy. In this way, protein can be ‘spared’ for synthesis of new tissue (Wilson, 
1989; Bell, 1998).  Although high lipid diets provide an invaluable energy source, they may also 
promote excessive fat deposition in tissues, including liver and flesh, which can affect the overall 
market quality of the fish (Sargent et al., 2002).  Furthermore, an increase in the production of farmed 
fish over the last decade, juxtaposed with a decline in finite sources of fish oil has prompted research 
into alternative sustainable feed formulations, primarily examining the potential for plant-derived oil 
replacement (Tacon, 2003; Sargent et al., 2002).  However, it has been suggested that vegetable oil 
replacements may also impact consumer welfare by reducing the amount of human health promoting n-
3 highly unsaturated fatty acids (HUFA) in fish (Tocher, 2003). The physiological and biochemical 
influences of potential dietary “functional foods” are currently being assessed in an attempt to alleviate 
the deleterious consequences of feeding fish high lipid level or alternative oil diets (Kennedy et al., 
2005, 2007).   Two of these prospective “functional” dietary supplements are the bioactive fatty acids, 
conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA). 
      The term CLA is used to denote positional, geometric and conjugated isomers of linoleic acid 
(18:2n-6), found naturally in dairy and meat produce; the two most biologically active isomers being 
cis-9, trans-11 and trans-10, cis-12 (Pariza et al., 2001). Dietary CLA exerts several beneficial effects 
on lipid metabolism in mammals and there is evidence to suggest that it can influence body 
composition by decreasing adiposity while increasing lean body mass in mammals (Keim, 2003). CLA 
has also been reported to alter the expression of a number of genes thought to be pivotal in maintaining 
lipid and fatty acid homeostasis (Ide, 2005).  Altered activities of enzymes involved in fatty acid 
metabolism have also been noted in a number of studies, signifying a possible biochemical modus 
operandi for anti-obesity effects in animals fed CLA (Ide, 2005).  Previous trials have shown that CLA 
may have beneficial effects in rainbow trout culture and can be supplemented to diets without any 
major deleterious effects (Figueiredo-Silva et al., 2005; Bandarra et al., 2006; Valente et al., 2007). 
However, these studies had used fish of 5g and 97g, far smaller than market size fish.  It would 
therefore be useful to elucidate whether dietary CLA could elicit more positive results in larger 
rainbow trout of commercial size and weight. 
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TTA belongs to the family of 3-thia fatty acids, which have been studied as a dietary supplement in 
mammals, but much less so in other vertebrates (Skrede et al., 1997).  Structurally, TTA is a 16 carbon 
saturated fatty acid that contains a sulphur atom at the third position from the carboxyl moiety.  In 
mammals, TTA is a peroxisome proliferator (Berge et al., 2002) has been shown to reduce body fat in 
rats (Madsen et al., 2002), and can affect various aspects of mammalian lipid metabolism (Berge et al., 
1989; Aarsland et al., 1989; Asiedu et al., 1993; Skrede and Bremer, 1993).  Recently, dietary TTA was 
shown to alter the expression of a number of hepatic genes involved in lipid metabolism in Atlantic 
salmon (Kleveland et al., 2006).  However, the authors also reported unexpectedly high mortalities in 
salmon fed TTA, which was not a feature of earlier trials with TTA in mammals (Berge et al., 2002).  
Here we report the influence of CLA and, for the first time, TTA, on growth and lipid composition 
and metabolism in market-size rainbow trout grown in seawater. Trout of almost 440g were fed for 
eight weeks on commercial formulated fish meal and fish oil based diets containing either 0.5% or 1% 
CLA, or 0.5% TTA and growth, feed efficiency, tissue lipid content, class and fatty acid compositions 
determined, along with activities of HUFA synthesis and key enzymes of fatty acid oxidation, and the 
expression of associated genes. 
 
2. Materials and methods 
 
2.1. Diets and Animals 
The dietary trial was performed at BioMar Forsøgs Station, Hirtshals, Denmark, between March and 
May 2006.  Stock, unpigmented rainbow trout  (Skinnerup, Moeldrup, Denmark) acclimated to 20 ppt 
salinity, were randomly distributed between twelve indoor, round tanks of 1 m3 volume (1.72 m 
diameter).  The initial stocking density was 25 fish of average weight 437 ± 56 g (< 13% CV) per tank 
(~10.5 kg/m3).  Water temperature was maintained at 15.5 ± 0.2 oC throughout the trial, with a light 
regime of 14L:10D.  Four experimental diets were fed to triplicate tanks for 55 days, with the feeding 
regime based on restricted feeding at 100% of BioMar recommended feeding tables.  The calculated 
feed ration was offered to the fish for 8 hr each day using automatic individual belt feeding units.  In 
order to facilitate accurate calculations of feed intake and FCR, feed waste was collected daily via a 
lift-up system. The experimental diets were formulated to satisfy the nutritional requirements of 
salmonid fish (National Research Council, 1993), and were formulated and manufactured by BioMar 
A/S, Brande, Denmark (Table 1). Moisture, oil, protein and ash contents of diets were determined by 
standard methods (AOAC, 2000).  The isonitrogenous diets were based on fish meal and standard 
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Northern hemisphere fish oil with CLA and TTA added to 0, 0.5 and 1% (CLA), and 0.5% (TTA) as 
percentages of total diet. Diets were identical in formulation other than fatty acid composition with 
CLA (LUTA-CLATM 60, containing 60% CLA methyl esters as a 50:50 mixture of c9, t11 and t10, c12 
isomers; BASF AG, Ludwigshafen, Germany) and TTA (gifted by Dr Rolf Berge, Thia Medica A.S., 
Bergen, Norway) balanced by fish oil of Northern hemisphere origin. The fatty acid compositions of 
the diets are presented in Table 2.  
 
2.2. Sampling protocols  
 
       At the initiation and termination of the trial, all the fish in each tank were anaesthetised with 
benzocaine (50mg/L), weighed and fork length measured individually.  At the end of the trial 23 fish 
per tank were killed by percussion, eviscerated and right-hand fillets removed for α-colour 
measurement by Minolta in triplicate along each fillet. Eight fish per tank (24 per dietary treatment) 
were sampled for biometric parameters (hepato-, and viscero-somatic indices).  Liver and white (fast) 
and red (slow) muscle samples from the Flesh Quality Cut (FQC - epaxial myotomes anterior to the 
first dorsal fin ray) were taken from eight fish per tank and immediately frozen on dry ice for 
biochemical and RNA analyses. All samples were subsequently stored at –80 oC prior to analyses.   
 
2.3. Lipid analyses  
 
     Liver and skinned and deboned flesh samples, each consisting of three fish, were homogenized into 
pooled “pates”. Total lipid was extracted from diets or 1g portions of tissue pates by homogenizing in 
20 volumes of chloroform/methanol (2:1, v/v) in an Ultra-Turrax tissue disrupter (Fisher Scientific, 
Loughborough, U.K.). Total lipid was prepared according to the method of Folch et al. (1957) and lipid 
content determined gravimetrically as described previously (Kennedy et al., 2005).  Tissue lipid class 
compositions were determined by single-dimension double-development high-performance thin-layer 
chromatography (HPTLC) and densitometry using a Camag 3 TLC Scanner (Camag, Muttenz, 
Switzerland) and winCATS software as described in Kennedy et al. (2005). Fatty acid methyl esters 
(FAME) from diets and tissue total lipid were prepared by acid-catalyzed transesterification of total 
lipid using 1% concentrated sulphuric acid in methanol similar to the method of Christie (1993) except 
that the reaction was performed at 80 oC for 3 h. Extraction and purification of FAME was performed 
as described by Tocher and Harvie (1988). FAME were separated and quantified by gas-liquid 
chromatography (Carlo Erba Vega 8160, Milan, Italy) using a 30m x 0.32 mm i.d. capillary column 
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(CP Wax 52CB, Chrompak, London, U.K.) and on-column injection. Hydrogen was used as carrier gas 
and temperature programming was from 50oC to 150oC at 40oC min-1 and then to 230oC at 2.0oC min-1.  
Methyl esters were identified and quantified as described previously (Kennedy et al., 2005). 
 
 2.4. Assay of carnitine palmitoylacyltransferase I (CPT-I), acylCoA oxidase (ACO), and highly 
unsaturated fatty acid (HUFA) synthesis 
 
Liver, red and white muscle were weighed, diced and homogenized to 20% (w/v) in 0.25 M sucrose in 
10 mM N-2-hydroxyethylpiperazine-N´-2-ethanesulfonic acid (HEPES) buffer and 1 mM EDTA, pH 
7.4. The homogenates were centrifuged at 1880 x g for 10 min at 4˚C, the floating fat layer aspirated 
and the post-nuclear fractions collected, 100 µl taken for protein determination according to Lowry et 
al. (1957) after incubation with 400 µl of 0.25% (w/v) SDS/1M NaOH for 45 min at 60oC, and portions 
used immediately for determination of enzyme activities. CPT-I activity was estimated by determining 
the production of palmitoyl[3H]carnitine from palmitoyl CoA and [3H]carnitine essentially as described 
by Saggerson and Carpenter (1986).  ACO activity was measured by a spectrophotometric assay based 
on the determination of hydrogen peroxide production coupled to the oxidation of leuco-
dichlorofluorescein (DCF) in a reaction catalyzed by exogenous peroxidase (Small et al., 1985).  For 
HUFA synthesis, microsomes were prepared from the liver homogenate and fatty acyl desaturation and 
elongation determined using [1-14C]18:3n-3 as substrate as described in detail in Kennedy et al. (2006). 
 
2.5. RNA extraction and real-time quantitative-polymerase chain reaction (Q-PCR).  
 
Total RNA from liver, red and white muscles was isolated, DNase treated and reverse transcribed into 
cDNA as described previously (Kennedy et al., 2006).  PCR primers were designed according to the 
trout cDNA sequences for CPT-I (accession no. AF327058), fatty acyl ∆6 desaturase (accession no. 
AF301910) and fatty acyl elongase (accession no. AY605100). Primer sequences and PCR product 
sizes are given Table 3, and all amplicons were subjected to agarose gel electrophoresis in order to 
confirm product size. Amplification of cDNA samples was carried out using the QuantiTect® SYBR 
Green PCR Kit (Qiagen, Crawley, UK) with the following conditions: 15 min at 95 oC to activate the 
HotStarTaq DNA polymerase, followed by 45 cycles of 15 s at 95 oC, 15 s at 56 oC and 30 s at 72 oC, 
followed by product melting to check purity of PCR product. Thermal cycling and fluorescence 
detection were conducted using the Rotor-Gene 3000 system (Corbett Research, Cambridge, UK).  
Three reference genes, elongation factor-1α (EF1α), β-actin and glyceraldehyde 3-phosphate 
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dehydrogenase (GAPDH), were used to normalise the expression data. The suitability of all three 
reference genes was determined via pair-wise correlation analysis using the BestKeeper© software 
(Pfaffl et al., 2004). Sample specific PCR efficiency (E) was determined using comparative 
quantitation analysis as part of the Rotor-Gene software. The data were subjected to a pair-wise fixed 
reallocation randomization test© (10000 randomisations) in order to determine significance between 
treatments as facilitated by Relative Expression Software Tool – Rotor-Gene (REST-RG© - version 3) 
(Pfaffl, et al., 2002).  
 
2.6. Materials 
 
    [1-14C] Palmitoyl CoA (50-55 mCi/mmol) and [methyl-3H] L-carnitine hydrochloride (60-86 
Ci/mmol) were obtained from GE Healthcare Bio-Sciences (Little Chalfont, Bucks, U.K.), and [1-
14C]18:3n-3 (50-55 mCi/mmol) was obtained from NEN (Perkin Elmer LAS (UK) Ltd., Beaconsfield, 
U.K.). Aminotriazole, BHT, carnitine, coenzyme A, EDTA, FAF-BSA, HEPES, horseradish 
peroxidase, leuco-DCF, malate, N-acetylcysteine, NADH, NADP, palmitoyl-CoA, and TriReagent 
were obtained from Sigma Chemical Co. (Poole, U.K.). TLC (20 cm x 20 cm x 0.25 mm) and HPTLC 
(10 cm x 10 cm x 0.15 mm) plates, precoated with silica gel 60 (without fluorescent indicator) were 
obtained from Merck (Darmstadt, Germany).  All solvents were HPLC grade and were obtained from 
Fisher Scientific UK, Loughborough, England. 
 
2.8. Statistical analysis 
 
         All data are presented as means ± SD (n value as stated). Percentage data and data which were 
identified as non-homogeneous (Bartlett’s test) were subjected to arcsine transformation before 
analysis.  Other than for gene expression (see above), the effects of dietary CLA and TTA were 
determined by one-way analysis of variance (ANOVA) with Tukey’s post-tests to determine 
significance of differences due to functional fatty acids. Differences were regarded as significant when 
P < 0.05 (Zar, 1999). 
 
3. Results  
 
3.1. Diet compositions 
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The control fish oil diet contained around 43% total polyunsaturated fatty acids (PUFA), including 
15% eicosapentaenoic acid (20:5n-3; EPA), 14% docosahexaenoic acid (22:6n-3; DHA) and almost 4% 
18:2n-6, 33% total saturates, mainly 16:0, and 24% total monoenes, mainly 18:1n-9 and 16:1n-7 (Table 
2).  Inclusion of CLA in the diets resulted in levels of total CLA of 1.8% and 4.0% of total fatty acids 
at the 0.5 and 1% inclusion levels, respectively, and inclusion of 0.5% TTA resulted in TTA at a level 
of 1.9% of total fatty acids in the diet.  
 
3.2. Growth and biometry 
 
There were no mortalities during the dietary trial. Growth of the trout was not affected by either CLA 
or TTA, with neither having any significant effect on final weights, SGRs, or feed efficiency (FCR) 
(Table 4).  Similarly, condition factor (K), yield, as measured by gutted weight, and fillet colour (α-
value) were unaffected by dietary treatment. There was a trend for lower viscero-somatic index (VSI) 
in fish fed CLA that was not statistically significant and HSI was not affected by either functional fatty 
acid (Table 4). 
 
3.3. Lipid contents and classes of liver and flesh 
 
     The total lipid content of the trout livers was significantly lower in fish fed CLA, but not TTA, 
compared to fish fed fish oil alone (Table 5). Neutral lipids accounted for around 60% of liver total 
lipid and there were no significant effects of diet. Dietary CLA and TTA had no effect on flesh lipid 
contents, which varied between 7.2 and 8.2% of wet weight, or on the proportions of polar and neutral 
lipids (Table 5).   
 
3.4. Fatty acid compositions of liver and flesh 
 
Dietary CLA and TTA were both incorporated into tissue lipids but proportions of CLA and TTA were 
higher in flesh than in liver.  Thus, CLA accounted for 0.6 and 1.1% of total fatty acids in livers of fish 
fed that fatty acid at 0.5 and 1% of diet, respectively, and TTA accounted for 0.9% of liver fatty acids 
in fish fed 0.5% TTA (Table 6).  In flesh, the proportion of CLA reached 1.1 and 1.6% of total fatty 
acids at the 0.5 and 1% inclusion levels, and TTA accumulated to 1.2% of flesh fatty acids in TTA-fed 
fish (Table 7).  The proportions of total PUFA, total n-3PUFA and arachidonic acid (AA, 20:4n-6) in 
liver were increased in fish fed both CLA and TTA (Table 6).  The numerical values of 20:5n-3 and 
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22:6n-3 in liver were consistently higher in fish fed CLA and TTA, but this only reached statistical 
significance with 20:5n-3 in fish fed 1% CLA.  Total saturated fatty acids and 18:0 were increased by 
CLA and total monoenes, particularly 18:1n-9 and 16:1n-7, were reduced in livers of fish fed both CLA 
and TTA.  Dietary CLA and TTA had no effect on the proportions of n-3 or n-6 PUFA in trout flesh, 
but CLA resulted in increased percentages of 18:0 and decreased percentages of 18:1n-9 (Table 7). 
 
3.5. Carnitine palmitoyltransferase-I (CPT-I) and acyl CoA oxidase (ACO) activities in liver, red and 
white muscle and HUFA synthesis in liver microsomes  
 
Dietary TTA significantly increased the activities of CPT-I (Fig.1) and ACO (Fig.2) in liver and red 
muscle compared to the activity in fish fed fish oil alone.  There was a trend for dietary CLA to 
increase ACO in liver and red muscle, but this effect was only significant in red muscle in fish fed the 
higher level of CLA (Fig.2). CPT-I activity was not affected by CLA in any of the three tissues, and 
there were no dietary effects of either supplemented fatty acid on CPT-I and ACO activities in white 
muscle.  Neither CLA nor TTA had any affect on the overall flux through the HUFA synthesis pathway 
as measured by summing all the desaturated products of 18:3n-3. However, both CLA and TTA 
increased the amount of radioactivity from labelled 18:3n-3 that was recovered in the hexaene fraction, 
significantly so in the case of TTA and the higher CLA level (Fig.3). 
 
3.6. Expression of carnitine palmitoyltransferase I (CPT-I) in liver, red and white muscle and fatty acyl 
desaturase and elongase in liver  
 
There was a clear trend for CPT-I expression to be increased by 0.5% CLA and TTA in all tissues, but 
the increased expression was only significant in white muscle with all dietary treatments compared to 
fish fed fish oil (Fig.4). The expression of fatty acyl Δ6 desaturase was significantly lower in fish fed 
CLA and TTA compared to fish fed fish oil alone, whereas the expression of PUFA elongase was 
increased by dietary CLA (Fig. 5). 
 
4. Discussion 
 
We tested the hypotheses that CLA and/or TTA would have beneficial effects on the nutritional quality 
of rainbow trout through decreased lipid content of flesh, and increased levels of beneficial fatty acids 
including accumulation of CLA or TTA. The results showed that the hypotheses were only partly 
 10 
proved. CLA or TTA accumulated in flesh, which may be beneficial to the human consumer if indeed 
these bioactive fatty acids are beneficial in human diets.  There is evidence that this may be the case 
with CLA (Riserus et al., 2001; Terpstra 2004; Wahle et al., 2004), but TTA is still largely untested in 
humans (Berge et al., 2002), although two recent studies suggest it may have lipid-lowering and anti-
inflammatory effects (Aukrust et al., 2003; Fredriksen et al., 2004). These issues of human nutrition 
are, of course, out with the scope of the present study. However, it appears that fish such as trout could 
be a convenient and consumer-friendly route for the delivery of bioactive or functional fatty acids in 
the human diet. The fatty acids can be easily incorporated into fish diets, the flesh accumulates CLA or 
TTA to a relatively greater extent than liver and, when combined with the relatively high flesh lipid 
content, means trout can deliver a reasonable dose of the bioactive fatty acids.  However, the levels of 
CLA accumulated in flesh in this trial with trout were lower than the levels obtained in previous trials 
with striped bass (Twibell et al., 2000), salmon (Berge et al., 2004; Kennedy et al., 2005), trout 
(Valente et al., 2007) and sea bass (Valente et al., 2007) fed CLA at an equivalent inclusion level. This 
is consistent with the fish used in these earlier trials being smaller than those used here, as the kinetics 
of fatty acid composition changes will be more rapid in smaller fish.  It is likely that higher levels of 
CLA and TTA could be achieved in larger fish with feeding periods longer than the 8 wks used in the 
present study. 
    Importantly, the accumulation of CLA or TTA did not significantly affect the levels of the n-3HUFA 
in flesh and therefore there was no effect on flesh fatty acid compositions that could be considered 
detrimental or likely to compromise the established nutritional benefit of fish for the human consumer.  
Indeed, it was noteworthy that one of the metabolic effects of the dietary bioactive fatty acids was the 
increased level of radioactivity recovered in the hexaene fraction in the HUFA synthesis assay. The 
hexaene fraction represented less than 10% of the total radioactivity recovered in desaturated products 
and could only contain 24:6n-3 as this was a microsomal assay, and peroxisomes are required for the 
conversion of 24:6n-3 to DHA in trout (Buzzi et al., 1997).  Even so, the liver fatty acid compositions 
showed a definite trend of increased proportions of DHA that was, at least, consistent with the fact that 
CLA and TTA may have a stimulatory effect on DHA synthesis. Previously, dietary CLA increased 
DHA in salmon fry (Berge et al., 2004), and dietary TTA significantly increased the percentage of 
DHA, and decreased the proportion of EPA, in flesh of cod (Kennedy et al., 2007). In contrast, CLA 
did not increase biosynthesis of DHA from 18:3n-3 in humans (Attar-Bashi et al., 2007). In the present 
study, total HUFA synthesis, as measured by the sum of all desaturated products recovered, was low in 
all dietary treatments, as expected in trout (Buzzi et al., 1996), and fish in general (Tocher 2003), fed 
essentially fish oil diets, and there was no effect of CLA or TTA on overall HUFA synthesis. Thus, the 
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effects of CLA and TTA were specifically to increase the proportion of the products of the pathway 
recovered as hexaenes rather than an increase in the overall activity of the HUFA synthesis pathway. 
Dietary CLA had no effect on the HUFA synthesis pathway in salmon fed diets with similar oil content 
to the diets in the present trial and, consistent with this, 1% CLA had no effect on fatty acid desaturase 
expression (Kennedy et al., 2006). Therefore, it was surprising that the expression of the trout 
desaturase gene in the present trial was greatly reduced by both CLA and TTA without affecting 
overall HUFA synthesis. The generally low level of HUFA synthesis, perhaps combined with a 
compensatory increase in PUFA elongase expression, may have mitigated the effect of decreased 
desaturase expression. The suppression of desaturase expression by CLA is not without precedent, as 
CLA has been shown to suppress PUFA desaturase and elongase in mammalian cell systems (Chuang 
et al., 2001a,b; Eder et al., 2002). The lack of a direct correlation between desaturase expression and 
HUFA synthesis may indicate that the effects of CLA or TTA were mediated through post-translational 
modification rather than transcriptional regulation.  
   CLA had very clear effects on the 18:0/18:1n-9 ratio with greatly increased 18:0, and decreased 
levels of 18:1n-9, in liver and, to a lesser extent, flesh lipids. Similar observations have been made 
previously in striped bass (Twibell et al., 2000), yellow perch (Twibell et al., 2001), salmon (Berge et 
al., 2004; Kennedy et al., 2006), cod (Kennedy et al., 2007) and sea bass (Valente et al., 2007). In 
addition, dietary CLA increased the proportions of 18:0 and decreased percentages of 18:1 in liver, 
muscle and viscera of rainbow trout juveniles (Bandarra et al., 2006). These data are entirely consistent 
with CLA inhibiting stearoyl CoA desaturase (SCD) in trout and fish in general.  In contrast, the data in 
the present study have shown that TTA has only a moderate on SCD in trout. The percentages of 18:0 
and 18:1n-9 in liver were only slightly altered and there was no effect in flesh.  Previously, dietary 
TTA was shown to have no major effects on 18:0/18:1n-9 levels in salmon liver, gill or heart lipids 
(Moya-Falcon et al., 2004), and cod liver or flesh lipids (Kennedy et al., 2007).  Similarly, TTA had no 
effect on 18:0/18:1n-9 levels in hepatocytes from salmon fed 0.6% TTA or in hepatocytes incubated 
with 0.8 mM TTA (Moya-Falcon et al., 2006). In contrast, TTA has been shown to up-regulate SCD in 
mammals (Madsen et al., 1997). 
    Dietary CLA can have beneficial effects on body composition in mammals, decreasing body fat and 
increasing lean body mass in mice, rats and pigs (Wang and Jones, 2004).  Similarly, TTA has been 
shown to prevent high fat diet induced adiposity in mammals (Madsen et al., 2002). However, there 
was no evidence that dietary CLA or TTA, at the levels used, could exert a beneficial effect on flesh 
lipid content in trout.  In two previous trials on salmonids, total lipid content of flesh in salmon and 
trout was not reduced by dietary CLA, although these trials used smaller animals compared to the 
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present trial, around 87g for the salmon smolts and only 5g for the trout (Kennedy et al., 2005; 
Bandarra et al., 2006). We reasoned that perhaps salmonids in those size ranges were not ideal for 
investigating bioactive fatty acids, which have effects on lipid oxidation and deposition, as fish at that 
stage of development will not be depositing large amounts of lipid in the flesh during the trials’ 
periods. Hence the reason larger fish were used, growing from approximately 400 g to almost 800 g, 
and for performing the trial in seawater in the present study. Although, due to the larger size of the fish, 
whole body proximate composition was not measured in the present trial, there was no suggestion from 
any of the biometric or tissue lipid analyses data to suggest a lipid reduction in the large trout by CLA 
or TTA. It has been consistently shown in previous trials that CLA had no significant effect on whole 
body proximate composition in fish (Twibell and Wilson, 2003; Berge et al., 2004; Figueirdo-Silva et 
al., 2005; Kennedy et al., 2005, 2007; Valente et al., 2007). Dietary TTA at 0.6%, but not 0.3%, 
reduced carcass fat in salmon (86g) (Moya-Falcon et al., 2004), and 0.5% TTA had no effect on cod 
proximate composition (Kennedy et al., 2007). Furthermore, the lipid content data in the present trial 
suggest no redistribution of fat between liver and flesh, and the unchanged HSI, VSI and K values are 
consistent with no major changes in fat distribution in general. Therefore, no significant effects of CLA 
and TTA on lipid deposition were observed, despite using larger fish. Thus, the evidence is not 
supportive of CLA or TTA having any commercially important effects on lipid deposition in 
salmonids.  
   In contrast to flesh, liver lipid was lowered by dietary CLA in the present study, and similar results 
were obtained previously in striped bass (Twibell et al., 2000), and yellow perch (Twibell et al., 2001) 
and 97g trout (Valente et al., 2007). Feeding CLA also reduced liver triacylglycerol levels in rats 
(Rahman et al., 2002) and, in rodents, studies have suggested that CLA increased fatty acid oxidation 
via an increase in CPT-I activity (Rahman et al., 2001; Degrace et al., 2004).  However, neither CPT-I 
nor ACO (key enzymes of mitochondrial and peroxisomal β-oxidation, respectively) were increased in 
liver by dietary CLA, and CPT-I expression in liver was also unaffected by either bioactive fatty acid.  
In contrast, TTA increased both CPT-I and ACO in trout liver, but this was not reflected in lower liver 
lipid, similar results to those obtained previously in cod (Kennedy et al., 2007). Therefore, the 
mechanism of decreased lipid content in liver of fish fed CLA is unclear as it does not appear to be 
related to fatty acid oxidation. This dissociation between tissue lipid levels and indicators of fatty acid 
oxidation was also observed in muscle tissue as TTA increased CPT-I and ACO in red muscle and high 
CLA increased red muscle ACO. This can perhaps be explained, however, as red muscle constitutes 
only a small proportion of flesh and so metabolic changes in it are not so likely to result in changes in 
overall flesh composition. In white muscle, which constitutes the bulk of flesh, CPT-I and ACO 
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activities were unaffected by CLA and TTA. Considering the lack of effect CPT-I activity, the 
increased CPT-I expression in white muscle of fish fed either CLA or TTA was a contradiction. 
Disparity between CPT-I activities and fatty acid oxidation in hamsters fed CLA has also been 
observed, and it was suggested that this may be due to increased sensitivity of CPT-I to malonyl-CoA 
in animals fed CLA (Bouthegourd et al., 2002). A similar mechanism could account for the lack 
association between CPT-I expression and activity in the present trial.  
     CLA has been studied to a far greater extent than TTA and so more potential effects are known.  For 
instance, CLA may have effects on growth performance in mammals as some studies have suggested 
that it can enhance growth and feed efficiency in young rodents (Pariza et al., 2001).  However, these 
effects on growth have not been replicated in previous trials on a variety of fish species (Twibell et al., 
2001; Twibell and Wilson, 2003; Berge et al., 2004; Yasmin et al., 2004; Kennedy et al., 2005, 2007; 
Manning et al., 2006), including small rainbow trout (Figuierdo-Silva et al., 2005; Valente et al., 2007).  
This trial with market size fish also showed no effect on growth at all.  Final weight, SGRs and FCRs 
were all unaffected by CLA or TTA at the levels tested. It was particularly noteworthy that there was 
no detrimental effect on growth or mortality in trout fed 0.5% TTA.  Previously, significant depressed 
growth and increased mortality was reported in salmon smolts fed 0.6% TTA (Moya-Falcon et al., 
2004), and a slight increase in mortality in cod fed 0.5% TTA (Kennedy et al., 2007).   
    In conclusion, the results of the present study only partly support the hypotheses that we set out to 
test.  Thus CLA or TTA did not beneficially alter the lipid content of the flesh in commercial size 
rainbow trout grown in seawater. However, trout preferentially accumulated CLA or TTA in the flesh 
compared to liver, with no detrimental effect on flesh n-3 HUFA levels.  Therefore, if CLA or TTA are 
proved to be beneficial in the human diet, trout may be a convenient and consumer-friendly source of 
these fatty acids, thus enhancing the nutritional quality through provision of n-3 HUFA and bioactive 
fatty acids. 
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Legends to Figures 
 
Fig.1. Effects of conjugated linoleic acid (CLA) or tetradecylthioacetic acid (TTA) on carnitine 
palmitoyltransferase-I (CPT-I) activities in tissue homogenates of liver, red and white muscle of 
rainbow trout. Results are presented relative to the activity in fish fed fish oil for each tissue and are 
means ± SD (n = 6).  Different letters denote significant differences between dietary treatments within 
each tissue. CLA1 and CLA2, fish fed 0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; 
TTA, fish fed 0.5% TTA. 
 
Fig.2. Effects of conjugated linoleic acid (CLA) or tetradecylthioacetic acid (TTA) on acyl CoA 
oxidase activities in tissue homogenates of liver, red and white muscle of rainbow trout. Results are 
presented relative to the activity in fish fed fish oil for each tissue and are means ± SD (n = 6). 
Different letters denote significant differences between dietary treatments within each tissue. CLA1 
and CLA2, fish fed 0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% 
TTA. 
 
Fig.3. Effects of conjugated linoleic acid (CLA) or tetradecylthioacetic acid (TTA) on total β-oxidation 
activities in tissue homogenates of liver, red and white muscle of rainbow trout. Results are presented 
relative to the activity in fish fed fish oil for each tissue and are means ± SD (n = 6). Different letters 
denote significant differences between dietary treatments within each tissue. CLA1 and CLA 2, fish fed 
0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% TTA. 
 
Fig.4. Effects of conjugated linoleic acid (CLA) or tetradecylthioacetic acid (TTA) on the expression of 
carnitine palmitoyltransferase-I (CPT-I) in the liver, red and white muscle of rainbow trout. Genes were 
determined by Q-PCR and normalised relative to three housekeeping genes as described in Materials 
and Methods. Results are presented relative to the activity in fish fed fish oil and are means ± SD (n = 
6). Different letters denote significant differences between dietary treatments. CLA1 and CLA 2, fish 
fed 0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% TTA. 
 
Fig.5. Effects of conjugated linoleic acid (CLA) or tetradecylthioacetic acid (TTA) on the expression of 
fatty acyl Δ6 desaturase and elongase genes in liver of rainbow trout.  Genes were determined by Q-
PCR and normalised relative to three housekeeping genes as described in Materials and Methods. 
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Results are presented relative to the activity in fish fed fish oil and are means ± SD (n = 6). Different 
letters denote significant differences between dietary treatments. CLA1 and CLA 2, fish fed 0.5% and 
1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% TTA. 
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Table 1. Formulations (percentage of dry ingredients) and proximate 
compositions (percentage of total diet) of experimental diets
Fishmeal
Sunflower meal
Wheat gluten
Legume seeds
Soya
Micronutrients
Fish oil
CLA
TTA
Moisture 7.3 ± 0.2 7.5 ± 0.1 7.6 ± 0.1 7.5 ± 0.2
Lipid 27.7 ± 1.1 25.7 ± 0.5 24.8 ± 0.7 24.7 ± 1.9
Protein 43.5 ± 0.6 42.1 ± 0.2 42.6 ± 1.1 42.6 ± 0.6
Ash 8.4 ± 0.3 8.4 ± 0.0 8.4 ± 0.3 8.5 ± 0.1
Results for proximate compositions are means ± S.D. (n=3). Micronutrients, 
includes essential amino acids (methionine and lysine), vitamins, minerals, and
astaxanthin (35 mg/kg Lucantin® Pink, BASF), Biomar A/S, Brande, Denmark.
FO, control diet containing fish oil alone; CLA1 and CLA2, diets supplemented 
with 0.5 and 1% CLA; TTA, diet supplemented with 0.5% TTA. There were
no significant differences in proximate compositions between the diets.
FO CLA1 CLA2 TTA
1414 14
41
10.7
10
14
0.4
22.5
0
21.7
0.8
0 0 0
2220.8
0
0.5
1.7
4
41 41 41
10.7 10.7 10.7
10 10 10
4 4 4
0.4 0.4 0.4
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containing conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA)
14:0 7.8 ± 0.2 7.7 ± 0.2 7.4 ± 0.2 7.9 ± 0.3
15:0 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0
16:0 20.2 ± 0.1 20.2 ± 0.3 19.6 ± 0.4 20.4 ± 0.5
18:0 4.2 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 4.2 ± 0.1
Total saturated1 33.3 ± 0.3 33.1 ± 0.6 32.2 ± 0.8 33.5 ± 0.9
16:1n-7 8.3 ± 0.2 a 8.1 ± 0.0 a 7.8 ± 0.0 b 8.2 ± 0.1 a
18:1n-9 8.3 ± 0.0 c 8.8 ± 0.1 b 9.4 ± 0.0 a 8.1 ± 0.1 d
18:1n-7 3.2 ± 0.1 3.2 ± 0.0 3.1 ± 0.1 3.3 ± 0.0
20:1n-9 1.5 ± 0.0 1.4 ± 0.0 1.4 ± 0.0 1.4 ± 0.1
22:1n-11 1.7 ± 0.2 1.7 ± 0.1 1.7 ± 0.0 1.7 ± 0.1
24:1n-9 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
Total monoenes2 23.9 ± 0.4 23.9 ± 0.3 24.2 ± 0.1 23.5 ± 0.3
CLA (9c,11t) 0.0 ± 0.0 c 0.9 ± 0.1 b 2.0 ± 0.2 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 0.9 ± 0.1 b 2.0 ± 0.2 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 1.9 ± 0.1 a
18:2n-6 3.7 ± 0.1 3.6 ± 0.0 3.8 ± 0.0 3.6 ± 0.0
20:4n-6 1.3 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 1.2 ± 0.0
Total n-6 PUFA3 6.3 ± 0.2 6.0 ± 0.1 6.0 ± 0.0 5.8 ± 0.1
18:3n-3 1.1 ± 0.0 1.1 ± 0.0 1.0 ± 0.0 1.1 ± 0.0
18:4n-3 2.8 ± 0.0 2.6 ± 0.0 2.6 ± 0.0 2.7 ± 0.0
20:4n-3 0.9 ± 0.1 1.0 ± 0.3 0.7 ± 0.0 0.7 ± 0.0
20:5n-3 15.3 ± 0.3 a 14.9 ± 0.1 ab 14.4 ± 0.1 b 15.2 ± 0.2 a
22:5n-3 1.8 ± 0.0 1.7 ± 0.0 1.6 ± 0.0 1.7 ± 0.0
22:6n-3 14.2 ± 0.2 a 13.6 ± 0.2 bc 13.2 ± 0.2 c 13.8 ± 0.3 ab
Total n-3 PUFA4 36.4 ± 0.3 a 35.1 ± 0.1 b 33.7 ± 0.3 c 35.3 ± 0.5 b
Total PUFA 42.7 ± 0.3 a 41.1 ± 0.1 b 39.7 ± 0.3 c 41.1 ± 0.6 b
n-3/n-6 5.8 ± 0.2 bc 5.9 ± 0.1 ab 5.6 ± 0.0 c 6.1 ± 0.0 a
Values are means ± SD (n = 3). An SD of 0.0 denotes a value of < 0.05. Superscript 
letters denote significant differences between diets as determined by ANOVA as
described in the Materials and Methods. PUFA, polyunsaturated fatty acids. 
1, includes 20:0, present in some samples at up to 0.3%.
2, includes 20:1n-7 present in some samples at up to 0.3%.
3, includes 18:3n-6, 20:2n-6, 20:3n-6 and 22:4n-6 present at up 0.4%.
4, includes 20:3n-3 present at up to 0.2%. 
Table 2. Fatty acid compositions (percentage of weight) of experimental diets  
FO CLA1 CLA2 TTA
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Table 3. Sequences of primers and PCR product sizes.
Gene Accession No. Primer Sequence Product size (bp)
CPT-I AF327058 Forward GCGCTATTCGACCAAAAAGA 133
Reverse CTAGTCGTGACCAGCCGTTT
Desaturase AF301910 Forward ACCTAGTGGCTCCTCTGGTC 119
Reverse CAGATCCCCTGACTTCTTCA
Elongase AY605100 Forward GAACAGCTTCATCCATGTCC 149
Reverse TGACTGCACATATCGTCTGG
Elongation factor 1α AF498320 Forward GAATTCTCCTCCCACAGGAT 119
Reverse ACGATGGGTTTTAATCAGCA
Actin AJ438158 Forward CAAGCAGGAGTACGACGAGT 110
Reverse CTGAAGTGGTAGTCGGGTGT
GAPDH AB066373 Forward GTCTCAGTGGTGGACCTGAC 149
Reverse GCCGTTGAAGTCTGAAGAGA
All genes are from rainbow trout. 
CPT-I, carnitine palmitoyltransferase-I; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
 26 
 
Table 4. Growth and biometric parameters of rainbow trout (Oncorhynchus mykiss) fed diets
containing conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA)
Initial weight (g) 429 ± 17 437 ± 2 450 ± 8 433 ± 12
Final weight (g) 755 ± 46 760 ± 7 777 ± 15 762 ± 21
SGR 1.06 ± 0.07 1.08 ± 0.07 1.02 ± 0.02 1.05 ± 0.03
FCR 0.99 ± 0.06 0.95 ± 0.08 1.03 ± 0.02 0.98 ± 0.01
Gutted weight (%) 83.7 ± 0.8 84.3 ± 0.7 84.6 ± 0.7 83.3 ± 0.6
Condition factor (K) 1.58 ± 0.02 1.58 ± 0.02 1.62 ± 0.04 1.58 ± 0.03
HSI 1.4 ± 0.1 1.4 ± 0.1 1.3 ± 0.1 1.5 ± 0.1
VSI 17.0 ± 1.1 15.7 ± 0.7 15.4 ± 0.7 16.7 ± 0.6
Pigmentation 12.6 ± 0.4 12.8 ± 0.5 12.8 ± 0.3 12.6 ± 0.4
Mortality (n)
All data are means ± S.D. with the triplicate tanks being the experimental units (n = 3). 
FCR, feed conversion ratio = feed consumed (kg )/ weight gain (kg); 
HSI, Hepato-somatic index =100 x liver weight x body weight-1; 
Pigmentation, Fillet α value (redness) as measured by Minolta (arbitrary units);
SGR, specific growth rate (%/day) = 100 x [(Final Weight / Initial Weight)/Days- 1]; 
VSI, Viscero-somatic index = 100 x viscera weight x body weight-1;  
There were no significant effects of dietary treatment as determined by ANOVA as  
described in the Materials and Methods.
0 0 0 0
FO CLA1 CLA2 TTA
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Table 5. Lipid content (percentage of wet weight) and polar/neutral lipid compositions
(percentage of total lipid) of liver and flesh  of rainbow trout (Oncorhynchus mykiss)  
fed conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA)
Lipid class
Liver
Lipid content 4.5 ± 0.1 a 3.7 ± 0.3 c 3.9 ± 0.4 bc 4.3 ± 0.4 ab
Total polar 37.6 ± 2.0 40.2 ± 3.7 41.3 ± 3.0 42.3 ± 2.6
Total neutral 62.4 ± 2.0 59.8 ± 3.7 58.7 ± 3.0 57.7 ± 2.6
Flesh
Lipid content 7.2 ± 0.6 7.2 ± 0.3 7.7 ± 0.5 8.2 ± 1.0
Total polar 12.4 ± 3.3 12.3 ± 1.9 11.2 ± 0.9 9.5 ± 1.1
Total neutral 87.6 ± 3.3 87.7 ± 1.9 88.8 ± 0.9 90.5 ± 1.1
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  
Superscript letters denote significant differences between dietary treatments as  
determined by ANOVA  as described in the Materials and Methods. 
FO CLA2 TTACLA 1
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of rainbow trout (Oncorhynchus mykiss) fed conjugated linoleic acid (CLA) and 
tetradecylthioacetic acid (TTA)
14:0 2.0 ± 0.2 1.8 ± 0.2 1.8 ± 0.1 1.8 ± 0.1
16:0 13.1 ± 1.1 a 12.6 ± 1.0 a 12.2 ± 0.5 ab 10.8 ± 1.1 b
18:0 8.2 ± 0.3 d 13.4 ± 0.5 b 14.8 ± 0.5 a 9.6 ± 0.4 c
Total saturated1 23.7 ± 1.3 b 28.3 ± 1.1 a 29.3 ± 0.5 a 22.6 ± 1.4 b
16:1n-7 4.7 ± 0.4 a 2.8 ± 0.3 bc 2.6 ± 0.2 c 3.2 ± 0.3 b
18:1n-9 17.7 ± 2.0 a 10.8 ± 1.8 bc 9.0 ± 0.9 c 12.2 ± 1.6 b
18:1n-7 3.4 ± 0.1 a 2.7 ± 0.2 b 2.6 ± 0.1 b 3.5 ± 0.2 a
20:1n-9 2.3 ± 0.3 a 1.9 ± 0.3 b 1.5 ± 0.1 c 2.6 ± 0.2 a
24:1n-9 0.4 ± 0.0 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
Total monoenes2 29.0 ± 2.2 a 19.1 ± 2.2 c 16.8 ± 1.2 c 22.5 ± 2.2 b
CLA (9c,11t) 0.0 ± 0.0 c 0.4 ± 0.1 b 0.7 ± 0.0 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 0.2 ± 0.0 b 0.4 ± 0.0 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 0.9 ± 0.1 a
18:2n-6 1.7 ± 0.1 ab 1.5 ± 0.1 c 1.6 ± 0.1 bc 1.8 ± 0.1 a
20:4n-6 2.2 ± 0.2 b 3.0 ± 0.4 a 2.9 ± 0.2 a 3.1 ± 0.4 a
22:4n-6 0.6 ± 0.0 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1
Total n-6 PUFA3 5.2 ± 0.4 b 6.0 ± 0.5 a 5.8 ± 0.3 ab 5.8 ± 0.3 ab
18:3n-3 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.1 0.6 ± 0.0
20:4n-3 0.6 ± 0.1 b 0.6 ± 0.0 b 0.7 ± 0.1 b 0.9 ± 0.2 a
20:5n-3 9.4 ± 0.4 b 10.2 ± 0.7 ab 10.5 ± 0.5 a 9.6 ± 0.5 b
22:5n-3 3.7 ± 0.4 b 3.6 ± 0.4 b 3.6 ± 0.3 b 4.9 ± 0.7 a
22:6n-3 27.7 ± 1.2 31.0 ± 1.8 31.5 ± 1.6 31.8 ± 1.0
Total n-3 PUFA4 42.2 ± 1.8 b 46.1 ± 1.9 a 47.0 ± 1.4 a 48.2 ± 1.0 a
Total PUFA 47.3 ± 2.1 b 52.0 ± 1.9 a 52.9 ± 1.5 a 53.9 ± 1.1 a
n-3/n-6 8.2 ± 0.4 7.8 ± 0.7 8.1 ± 0.3 8.4 ± 0.5
0.0 denotes a value of < 0.05. Superscript letters denote significant differences
1, includes 15:0 and 20:0, present in some samples at up to 0.2%. 
2, includes 20:1n-7and 22:1n-11, present in some samples at up to 0.3%.
3, includes 20:2n-6 and 20:3n-6 present in some samples at up to 0.4%.
4, includes 18:4n-3 and 20:3n-3 present in some samples at up to 0.2%.
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  An SD of 
between dietary treatments as determined by ANOVA  as described in the  
Materials and Methods.  PUFA, polyunsaturated fatty acids. 
Table 6. Fatty acid composition (percentage of weight) of total lipid from liver 
FO CLA1 CLA2 TTA
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of rainbow trout (Oncorhynchus mykiss) fed conjugated linoleic acid (CLA) 
and tetradecylthioacetic acid (TTA)
14:0 5.9 ± 0.4 5.6 ± 0.3 5.8 ± 0.2 5.9 ± 0.4
15:0 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0
16:0 19.1 ± 0.6 18.9 ± 0.4 18.9 ± 0.4 18.9 ± 0.4
18:0 4.4 ± 0.3 b 5.3 ± 0.2 a 5.0 ± 0.5 a 4.4 ± 0.1 b
Total saturated 30.0 ± 1.2 30.2 ± 0.7 30.2 ± 0.8 29.8 ± 0.7
16:1n-7 7.2 ± 0.4 6.8 ± 0.1 6.9 ± 0.2 7.0 ± 0.2
18:1n-9 13.4 ± 0.6 a 12.4 ± 0.4 b 12.7 ± 0.2 b 12.8 ± 0.6 ab
18:1n-7 3.5 ± 0.1 3.5 ± 0.1 3.4 ± 0.1 3.6 ± 0.1
20:1n-9 2.8 ± 0.3 ab 2.5 ± 0.3 b 3.1 ± 0.2 a 2.8 ± 0.3 ab
22:1n-11 2.5 ± 0.4 ab 2.2 ± 0.3 b 2.9 ± 0.2 a 2.4 ± 0.4 ab
24:1n-9 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.1
Total monoenes1 30.1 ± 0.5 a 28.1 ± 0.9 b 29.7 ± 0.5 a 29.3 ± 0.8 a
CLA (9c,11t) 0.0 ± 0.0 c 0.6 ± 0.1 b 0.9 ± 0.2 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 0.5 ± 0.1 b 0.7 ± 0.1 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 1.2 ± 0.1 a
18:2n-6 4.8 ± 0.8 5.5 ± 0.7 4.6 ± 0.3 5.4 ± 0.9
20:4n-6 0.9 ± 0.0 1.0 ± 0.0 0.9 ± 0.0 0.9 ± 0.0
Total n-6 PUFA2 6.7 ± 0.8 7.5 ± 0.7 6.4 ± 0.3 7.0 ± 0.9
18:3n-3 1.2 ± 0.2 1.2 ± 0.0 1.2 ± 0.1 1.3 ± 0.1
18:4n-3 1.5 ± 0.1 1.4 ± 0.1 1.6 ± 0.1 1.5 ± 0.1
20:4n-3 1.3 ± 0.1 1.3 ± 0.1 1.1 ± 0.2 1.4 ± 0.2
20:5n-3 8.7 ± 0.3 8.7 ± 0.2 8.4 ± 0.2 8.5 ± 0.2
22:5n-3 2.9 ± 0.1 2.9 ± 0.0 2.7 ± 0.1 3.0 ± 0.2
22:6n-3 17.3 ± 1.1 17.5 ± 0.4 16.8 ± 0.5 16.8 ± 0.6
Total n-3 PUFA3 33.2 ± 1.2 33.2 ± 0.3 32.0 ± 0.8 32.8 ± 0.7
Total PUFA 39.9 ± 1.1 a 40.7 ± 0.8 a 38.5 ± 0.5 b 39.7 ± 0.7 ab
n-3/n-6 5.0 ± 0.7 4.5 ± 0.4 5.0 ± 0.3 4.8 ± 0.6
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  An SD of  
1, includes 20:1n-7 present in some samples at up to 0.3%.
2, includes 20:2n-6, 20:3n-6 and 22:4n-6 present in some samples at up 0.3%.
3, includes 20:3n-3 present at up to 0.3%. 
Materials and Methods.  PUFA, polyunsaturated fatty acids.
0.0 denotes a value of < 0.05. Superscript letters denote significant differences
Table 7. Fatty acid composition (percentage of weight) of total lipid from flesh  
FO CLA1 CLA2 TTA
between dietary treatments as determined by ANOVA  as described in the 
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